Estimation of Health State Utility Values for Immunoglobulin A Nephropathy: A Time Trade-Off Analysis.
Zheng-Yi ZhouMark E BensinkNisha C HazraChunyi XuBruce M HendryClaire C SharpeMo ZhouPublished in: PharmacoEconomics - open (2024)
Our results indicated that various IgAN health states are associated with impaired health status, with substantial utility decrements related to disease progression, elevated proteinuria, and nephrotic syndrome.